Astellas Pharma, Inc. (ALPMY)
13.29
-0.07
(-0.52%)
USD |
OTCM |
Dec 31, 16:00
Astellas Pharma Price: 13.29 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 24.90 |
| Takeda Pharmaceutical Co., Ltd. | 15.59 |
| Nxera Pharma Co., Ltd. | 5.48 |
| PeptiDream Inc. | 12.48 |
| Stemcell Holdings, Inc. | 0.06 |
Price Related Metrics
| PE Ratio | 27.78 |
| PS Ratio | 1.771 |
| PEG Ratio | 0.1957 |
| Price to Book Value | 2.180 |
| Price to Free Cash Flow | 10.31 |
| Earnings Yield | 3.60% |
| Market Cap | 23.81B |
| PEGY Ratio | 0.1957 |
| Operating PE Ratio | 9.861 |
| Normalized PE Ratio | 27.78 |